Guojing Zhang
ORCID: 0000-0003-3843-3672Also affiliated with Shanghai Electric (China)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 8 papers. Top paper: “Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study”.
Kristin Higgins, Zhengjia Chen, Gabriel Sica, Conor Steuer, Chao Zhang +12 more
Guojing Zhang, Jiani Yang, Ziyu Hao, Weijia Xing, Dong Lu +3 more
Bhakti Dwivedi, Zhengjia Chen, Chao Zhang, Benjamin G. Barwick, Vinicius Ernani +13 more
Zhen Chen, Hongjing Zang, Songqing Fan, Jiajia Gu, Guojing Zhang +7 more
Abbe Pannucci, Andrei A. Ivanov, Jeffrey M. Switchenko, Shi‐Yong Sun, Gabriel Sica +5 more
Andrei A. Ivanov, Guojing Zhang, Fadlo R. Khuri, Suresh S. Ramalingam, Haian Fu +3 more
Abu Syed Md Anisuzzaman, Andrew T. Magis, Guo Chen, Maohua Xie, Guojing Zhang +6 more
Hui Liu, Bin Zhou, Jessica Chung, Guojing Zhang, Jin Chang +4 more